KR100533911B1 - 아민 산화효소의 활성을 갖는 혈관 점착 단백질-1 - Google Patents

아민 산화효소의 활성을 갖는 혈관 점착 단백질-1 Download PDF

Info

Publication number
KR100533911B1
KR100533911B1 KR10-1999-7010888A KR19997010888A KR100533911B1 KR 100533911 B1 KR100533911 B1 KR 100533911B1 KR 19997010888 A KR19997010888 A KR 19997010888A KR 100533911 B1 KR100533911 B1 KR 100533911B1
Authority
KR
South Korea
Prior art keywords
vap
cells
sequence
delete delete
protein
Prior art date
Application number
KR10-1999-7010888A
Other languages
English (en)
Korean (ko)
Other versions
KR20010012920A (ko
Inventor
시르파 잘카넨
마르코 살미
데이비드 존 스미스
페트리 보노
Original Assignee
바이오티에 세라피스 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25338478&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100533911(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 바이오티에 세라피스 코포레이션 filed Critical 바이오티에 세라피스 코포레이션
Publication of KR20010012920A publication Critical patent/KR20010012920A/ko
Application granted granted Critical
Publication of KR100533911B1 publication Critical patent/KR100533911B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0022—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR10-1999-7010888A 1997-05-23 1998-05-22 아민 산화효소의 활성을 갖는 혈관 점착 단백질-1 KR100533911B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86243397A 1997-05-23 1997-05-23
US08/862,433 1997-05-23
PCT/FI1998/000429 WO1998053049A1 (en) 1997-05-23 1998-05-22 Vascular adhesion protein-1 having amine oxidase activity

Publications (2)

Publication Number Publication Date
KR20010012920A KR20010012920A (ko) 2001-02-26
KR100533911B1 true KR100533911B1 (ko) 2005-12-06

Family

ID=25338478

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-1999-7010888A KR100533911B1 (ko) 1997-05-23 1998-05-22 아민 산화효소의 활성을 갖는 혈관 점착 단백질-1

Country Status (12)

Country Link
EP (1) EP0979271A1 (zh)
JP (1) JP2001507238A (zh)
KR (1) KR100533911B1 (zh)
CN (1) CN1269829A (zh)
AU (1) AU742098B2 (zh)
CA (1) CA2289903A1 (zh)
HU (1) HUP0002234A3 (zh)
NO (1) NO995725D0 (zh)
NZ (1) NZ501118A (zh)
PL (1) PL192459B1 (zh)
RU (1) RU2204838C2 (zh)
WO (1) WO1998053049A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7285416B2 (en) 2000-01-24 2007-10-23 Gendaq Limited Regulated gene expression in plants
CA2433408A1 (en) * 2001-02-23 2002-08-29 Biovitrum Ab Method for purification of soluble ssao
FI20020807A0 (fi) * 2002-04-29 2002-04-29 Biotie Therapies Oyj Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita
EP1633861B1 (en) * 2003-05-26 2009-11-04 Biotie Therapies Corp. Crystalline vap-1 and uses thereof
FI20050640A0 (fi) * 2005-06-16 2005-06-16 Faron Pharmaceuticals Oy Yhdisteitä amiinioksidaasista riippuvien sairauksien tai häiriöiden hoitoon tai estoon
RU2009130380A (ru) 2007-01-10 2011-02-20 Санофи-Авентис (Fr) Способ определения стабильности органических метиленаминов в присутствии семикарбазид-чувствительной аминоксидазы
FI20075278A0 (fi) 2007-04-20 2007-04-20 Biotie Therapies Corp Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet
UA112154C2 (uk) * 2009-09-08 2016-08-10 Біоті Терапіс Корп. Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US39447A (en) * 1863-08-04 Improvement in truss-bridges

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0656906B1 (en) * 1992-06-09 1999-09-08 Oy Biotie Therapies A novel endothelial cell molecule mediating lymphocyte binding in man

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US39447A (en) * 1863-08-04 Improvement in truss-bridges

Also Published As

Publication number Publication date
HUP0002234A3 (en) 2005-11-28
JP2001507238A (ja) 2001-06-05
CN1269829A (zh) 2000-10-11
HUP0002234A2 (hu) 2000-10-28
KR20010012920A (ko) 2001-02-26
RU2204838C2 (ru) 2003-05-20
AU7531498A (en) 1998-12-11
CA2289903A1 (en) 1998-11-26
PL192459B1 (pl) 2006-10-31
PL337004A1 (en) 2000-07-31
NZ501118A (en) 2002-08-28
NO995725L (no) 1999-11-22
EP0979271A1 (en) 2000-02-16
WO1998053049A1 (en) 1998-11-26
AU742098B2 (en) 2001-12-20
NO995725D0 (no) 1999-11-22

Similar Documents

Publication Publication Date Title
Hoops et al. Isolation of the cDNA encoding glycoprotein-2 (GP-2), the major zymogen granule membrane protein: homology to uromodulin/Tamm-Horsfall protein
US5237051A (en) Purified enterotoxin receptor protein
Rana et al. Cloning of human erythroid dematin reveals another member of the villin family.
US20030092175A1 (en) Human proteins having transmembrane domains and dnas encoding these proteins
EP0533350A1 (en) DNA encoding precursor interleukin 1B converting enzyme
WO1998055621A1 (en) Ntn-2 member of tnf ligand family
JPH08500242A (ja) インターロイキン１β前駆体の転換酵素をコードするＤＮＡ
CA2299619A1 (en) Human orphan receptor ntr-1
KR100533911B1 (ko) 아민 산화효소의 활성을 갖는 혈관 점착 단백질-1
Armstrong et al. Rat lysyl hydroxylase: molecular cloning, mRNA distribution and expression in a baculovirus system
US6130039A (en) Polynucleotide encoding human lysyl hydroxylase-like protein
AU2207999A (en) Novel nucleic acid and polypeptide
US6627735B2 (en) Islet cell antigen 1851
US5989862A (en) Tab1 protein and DNA coding therefor
AU5311696A (en) Human restrictin and nucleic acid sequences
CA2076159C (en) Dna encoding precursor interleukin 1beta converting enzyme
US20040126858A1 (en) Novel polypeptide-nadp dependent leukotriene b412-hydroxydehydrogenase-36 and the polynucleotide encoding said polypeptide
US6844323B2 (en) Polypeptide-calcitonin 11 and the polynucleotide encoding it
US20040034210A1 (en) Novel polypeptide-protein p125-77.22 and a polynucleotide encoding the same
WO1997003200A1 (en) Nucleic acid coding for cmp-n-acetyl-neuraminic acid hydroxylase and its use for the production of modified glycoproteins
US20040091861A1 (en) Novel polypeptide-human shc protein 43 and polynucleotide encoding it
US20040248091A1 (en) Novel polypeptide-human g-protein and the polynucleotide encoding the same
WO1995015379A1 (en) Chicken oocyte receptor p95 (vldl/vtg receptor)
MXPA99004356A (en) Human proteins having transmembrane domains and dnas encoding these proteins
CA2400531A1 (en) Human nhe2

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20121109

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20131118

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20141110

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20151116

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20161121

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20171110

Year of fee payment: 13

EXPY Expiration of term